Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New device aims to prevent blood type Mix-Ups at bedside

NCT ID NCT04344613

Diagnosis Sponsor: Francis Corazza Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled This study
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study was designed to test a new device that checks a patient's blood type and the blood bag's type at the bedside before a transfusion. The goal was to prevent dangerous mismatched transfusions by giving a simple 'go' or 'no-go' result in about two minutes. However, the trial was withdrawn before any participants were enrolled, so no results are available.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
ABODpoct device
What this could lead to
If it works, this device could help prevent dangerous mismatched blood transfusions by giving a quick, clear 'go' or 'no-go' result at the bedside.
What could go wrong
The trial was withdrawn before any patients were enrolled, so no data were collected. The device is still in early development and may not prove reliable in real-world use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Started

Apr 2020

Finished

Oct 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Up to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * For the device evaluation inside the laboratory : every patient for whom a blood group is ordered to the blood transfusion laboratory. * For the device bedside evaluation : each patient from the hematology unit (one day clinic) requiring a transfusion. Exclusion Criteria: * Emergency circumstances requiring an urgent transfusion * Patient older than 80 years old * Patients with venous access

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Blood transfusion complication are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Transfusion Reaction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Blood transfusion complication

Contacts and locations

Locations

  • CHU Brugmann

    Brussels, 1020, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.